These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 29511912)
1. Single-institution experience with selective internal radiation therapy (SIRT) for the treatment of unresectable colorectal liver metastases. O'Leary C; Greally M; McCaffrey J; Hughes P; Lawler LLP; O'Connell M; Geoghegan T; Farrelly C Ir J Med Sci; 2019 Feb; 188(1):43-53. PubMed ID: 29511912 [TBL] [Abstract][Full Text] [Related]
2. Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT. Garrean S; Muhs A; Bui JT; Blend MJ; Owens C; Helton WS; Espat NJ World J Gastroenterol; 2007 Jun; 13(21):3016-9. PubMed ID: 17589957 [TBL] [Abstract][Full Text] [Related]
3. Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study. Xing M; Prajapati HJ; Dhanasekaran R; Lawson DH; Kokabi N; Eaton BR; Kim HS Am J Clin Oncol; 2017 Feb; 40(1):27-34. PubMed ID: 25089529 [TBL] [Abstract][Full Text] [Related]
4. FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer. Dutton SJ; Kenealy N; Love SB; Wasan HS; Sharma RA; BMC Cancer; 2014 Jul; 14():497. PubMed ID: 25011439 [TBL] [Abstract][Full Text] [Related]
5. Liver Resection for Colorectal Hepatic Metastases after Systemic Chemotherapy and Selective Internal Radiation Therapy with Yttrium-90 Microspheres: A Systematic Review. Baltatzis M; Siriwardena AK Dig Surg; 2019; 36(4):273-280. PubMed ID: 29886488 [TBL] [Abstract][Full Text] [Related]
6. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. Gibbs P; Gebski V; Van Buskirk M; Thurston K; Cade DN; Van Hazel GA; BMC Cancer; 2014 Dec; 14():897. PubMed ID: 25487708 [TBL] [Abstract][Full Text] [Related]
17. Multimodal sequential approach in colorectal cancer liver metastases: hepatic resection after yttrium-90 selective internal radiation therapy and cetuximab rescue treatment. Pini S; Pinto C; Angelelli B; Giampalma E; Blotta A; Di Fabio F; Santini D; Golfieri R; Martoni AA Tumori; 2010; 96(1):157-9. PubMed ID: 20437875 [TBL] [Abstract][Full Text] [Related]
18. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer. Fendler WP; Philippe Tiega DB; Ilhan H; Paprottka PM; Heinemann V; Jakobs TF; Bartenstein P; Hacker M; Haug AR J Nucl Med; 2013 Aug; 54(8):1202-8. PubMed ID: 23729697 [TBL] [Abstract][Full Text] [Related]
19. Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes. Mafeld S; Littler P; Hayhurst H; Manas D; Jackson R; Moir J; French J J Gastrointest Cancer; 2020 Mar; 51(1):152-158. PubMed ID: 30911980 [TBL] [Abstract][Full Text] [Related]
20. Quality of life in the FOXFIRE, SIRFLOX and FOXFIRE-global randomised trials of selective internal radiotherapy for metastatic colorectal cancer. Wolstenholme J; Fusco F; Gray AM; Moschandreas J; Virdee PS; Love S; Van Hazel G; Gibbs P; Wasan HS; Sharma RA Int J Cancer; 2020 Aug; 147(4):1078-1085. PubMed ID: 31840815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]